Oral neratinib regulatory update

Puma said it will delay to 1Q16 from 1H15 its NDA submission for neratinib for

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE